Correlation Between Unicycive Therapeutics and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Unicycive Therapeutics and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Achilles Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Achilles Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Unicycive and Achilles is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Achilles Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 2.68 times more return on investment than Achilles Therapeutics. However, Unicycive Therapeutics is 2.68 times more volatile than Achilles Therapeutics PLC. It trades about 0.05 of its potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.02 per unit of risk. If you would invest 45.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 24.00 from holding Unicycive Therapeutics or generate 53.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Achilles Therapeutics PLC
Performance |
| Timeline |
| Unicycive Therapeutics |
| Achilles Therapeutics PLC |
Unicycive Therapeutics and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Achilles Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |